News
-
-
-
COMMUNIQUÉ DE PRESSE
Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Biomind Labs Inc. to list Common Shares on the Canadian Securities Exchange (CSE) under symbol 'BMND' starting August 11, 2026, delisting from Cboe Canada on August 10, 2026. No action needed from shareholders. Company focused on CNS therapeutics -
-
-
COMMUNIQUÉ DE PRESSE
Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States
President Trump signs executive order to fast-track research and patient access to psychedelic therapies, aligning with Biomind's mission to transform neuropsychiatric care -
-
-
-